Canada markets closed

Geron Corporation (GERN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.43000.0000 (0.00%)
At close: 4:00PM EDT

1.4300 0.00 (0.00%)
After hours: 6:15PM EDT

Full screen
Trade prices are not sourced from all markets
Previous Close1.4300
Open1.4100
Bid1.4200 x 3200
Ask1.4400 x 40000
Day's Range1.3800 - 1.4400
52 Week Range1.2200 - 2.4000
Volume983,567
Avg. Volume2,968,959
Market Cap455.552M
Beta (5Y Monthly)1.11
PE Ratio (TTM)N/A
EPS (TTM)-0.2880
Earnings DateAug. 04, 2021 - Aug. 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Geron Announces Two Presentations at Upcoming European Hematology Association Annual Congress
    Business Wire

    Geron Announces Two Presentations at Upcoming European Hematology Association Annual Congress

    Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that two poster presentations of new clinical data and analyses related to imetelstat, the Company’s first-in-class telomerase inhibitor, will be made at the European Hematology Association (EHA) Annual Congress meeting to be held virtually from June 9 - 17. The abstracts for the posters are available on the EHA website at www.ehaweb.org. Both posters will be published on the EHA Virtual Congress platform on June 11, 2021.

  • Geron (GERN) Q1 2021 Earnings Call Transcript
    Motley Fool

    Geron (GERN) Q1 2021 Earnings Call Transcript

    Good day and thank you for standing by and welcome to the Q1 2021 Geron earnings conference call. Welcome to this conference call to discuss Geron's first-quarter 2021 financial results and recent company events.

  • Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates
    Zacks

    Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates

    Geron (GERN) delivered earnings and revenue surprises of -12.50% and 82.67%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?